Evidence map›Paper›PMID 40708986›Full record

ArticleBioengineering & translational medicine2025

Capture of Group A

Wan-Chen Tu, Ingrid H Robertson, Andrea Blom, Elena Alfaro, Victoria A M Shinkawa, Daniel B Hatchett, Juan C Sanchez, Anika M McManamen, Xiaojing Su, Erwin Berthier and 4 more

Abstract read
In one paragraph

Article in Bioengineering & translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Capture of Group ABioengineering & translational medicine · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Wan-Chen TuDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0002-2082-7799
Ingrid H RobertsonDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0009-0008-4217-4777
Andrea BlomDepartment of Pediatrics University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
Elena AlfaroDepartment of Pediatrics University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
Victoria A M ShinkawaDepartment of Chemistry University of Washington Seattle Washington USA.
Daniel B HatchettDepartment of Chemistry University of Washington Seattle Washington USA.
Juan C SanchezDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0009-0009-9406-6767
Anika M McManamenDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0001-5166-5879
Xiaojing SuDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0002-0174-2327
Erwin BerthierDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0002-4421-9034
Sanitta ThongpangDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0002-7920-2080
Ellen R WaldDepartment of Pediatrics University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.ORCID https://orcid.org/0000-0001-9305-8532
Gregory P DeMuriDepartment of Pediatrics University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.ORCID https://orcid.org/0000-0001-6008-8292
Ashleigh B ThebergeDepartment of Chemistry University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0002-3394-1435

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Sheela Sathyanarayana · 1995 to 2026
$42.5M
Theberge Admin Supp Undergraduate Summer Research ExperiencesR35GM128648 · NIGMS · UNIVERSITY OF WASHINGTON · PI Ashleigh Brooks Theberge · 2018 to 2026
$4.7M
Microengineered Lollipop for Patient-Centric Saliva CollectionR21AI166120 · NIAID · UNIVERSITY OF WASHINGTON · PI DEMURI, GREGORY P, THEBERGE, ASHLEIGH BROOKS · 2022 to 2023
$442k
NIAID NIH HHS R21 AI166120NIEHS NIH HHS P30 ES007033NIGMS NIH HHS R35 GM128648
6 · The paper itself

Abstract

State the Purpose: Obtaining high-quality samples to diagnose streptococcal pharyngitis in pediatric patients is challenging due to discomfort associated with traditional pharyngeal swabs. This may cause reluctance to go to the clinic, inaccurate diagnosis, or inappropriate treatment for children with sore throats. Here, we determined the efficacy of CandyCollect, a lollipop-inspired open-microfluidic pathogen collection device, to capture Group A Results: All child participants (30/30) were positive for GAS by qPCR on both the mouth swab and CandyCollect. Caregivers ranked CandyCollect as a good sampling method overall (27/30), and all caregivers (30/30) would recommend CandyCollect for children 5 years and older. Twenty-three of 30 children "really like" the taste and 24/30 would prefer to use CandyCollect if a future test were needed. All caregivers (30/30) and most children (28/30) would be willing to use CandyCollect at home. Conclusion: All participants tested positive for GAS on all three collection methods (pharyngeal swab, mouth swab, and CandyCollect). While both caregivers and children like CandyCollect, some caregivers would prefer a shorter collection time. Future work includes additional studies with larger cohorts presenting with pharyngitis of unknown etiology and shortening collection time while maintaining the attractive form of the device.

Indexed as

group A Streptococcusopen microfluidicspatient centric sample collection, point‐of‐carepediatric diagnostics

Identifiers

PMID40708986
PMCPMC12284423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.